Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine if pressurechamber treatment (HBOT) can reduce early
stages of breast cancer related lymphedema, and to explore the mechanisms involved in the
disease progress.